Stage III Grade 3 Follicular Lymphoma Completed Phase Trials for Valganciclovir (DB01610)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma) | Completed | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01199562 | Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant | Supportive Care |